Definitive Healthcare IPO Raises $420m

Healthcare commercial data and intelligence firm Definitive Healthcare has seen its stock rise sharply in its first days of Nasdaq trading, after raising $420m in its IPO.

The company began trading last Wednesday at $37.25 per share, 38% above the IPO price of $27.00, and is currently around $45.

Definitive focuses on converting data, analytics and expertise into healthcare commercial intelligence. Last year, the company acquired Monocl, which provides medical and scientific expert data and insights; having previously taken over the data services business and assets of HIMSS Analytics; and Billian's HealthData, which provides data and analytics on US healthcare organizations.

On Tuesday, Definitive Healthcare announced the pricing of its IPO on the Nasdaq, offering 15.6 million shares at $27.00 per share, having previously filed to offer the same amount of shares at a range of $21.00 to $24.00. The stock is listed on the Nasdaq exchange under the ticker symbol 'DH', and according to reports, with the revised pricing, the company could be valued at up to $3.9 billion.

Proceeds from the IPO will be invested in new data and analytics capabilities. CEO Jason Krantz (pictured) comments: 'Everyone at Definitive Healthcare is super excited about our transition to a publicly traded company. It's a significant milestone in our journey. But we didn't get here alone. Going public is a milestone that's a testament to the creativity, innovation and hard work of our more than 600 employees and the partnership of our more than 2,600 customers working to transform the healthcare industry'.

Web site: www.definitivehc.com .